Loss of USP22 expression delays prototypical TBZ‐induced necroptosis in several human tumor cell lines, and necroptosis resistance positively correlates with USP22 expression levels, relying on the catalytic USP22 DUB activity. This evidence concerns the gene ZUP1 and neoplasm.